NovaBay Pharmaceuticals Inc (NBY)
0.091
0.00 (0.00%)
USD |
NYAM |
May 06, 16:00
0.0909
0.00 (0.00%)
After-Hours: 04:33
NovaBay Pharmaceuticals Revenue (TTM): 14.73M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 14.73M |
| September 30, 2023 | 14.64M |
| June 30, 2023 | 15.20M |
| March 31, 2023 | 14.26M |
| December 31, 2022 | 14.40M |
| September 30, 2022 | 13.93M |
| June 30, 2022 | 12.37M |
| March 31, 2022 | 10.84M |
| December 31, 2021 | 9.378M |
| September 30, 2021 | 8.093M |
| June 30, 2021 | 7.998M |
| March 31, 2021 | 9.849M |
| December 31, 2020 | 9.934M |
| September 30, 2020 | 9.75M |
| June 30, 2020 | 9.195M |
| March 31, 2020 | 7.00M |
| December 31, 2019 | 6.599M |
| September 30, 2019 | 8.52M |
| June 30, 2019 | 10.05M |
| March 31, 2019 | 11.05M |
| December 31, 2018 | 12.51M |
| September 30, 2018 | 15.20M |
| June 30, 2018 | 16.15M |
| March 31, 2018 | 17.48M |
| December 31, 2017 | 18.23M |
| Date | Value |
|---|---|
| September 30, 2017 | 15.99M |
| June 30, 2017 | 15.34M |
| March 31, 2017 | 13.88M |
| December 31, 2016 | 11.90M |
| September 30, 2016 | 9.455M |
| June 30, 2016 | 7.217M |
| March 31, 2016 | 5.562M |
| December 31, 2015 | 4.381M |
| September 30, 2015 | 3.237M |
| June 30, 2015 | 2.189M |
| March 31, 2015 | 1.304M |
| December 31, 2014 | 1.054M |
| September 30, 2014 | 1.073M |
| June 30, 2014 | 2.02M |
| March 31, 2014 | 2.745M |
| December 31, 2013 | 3.477M |
| September 30, 2013 | 4.08M |
| June 30, 2013 | 6.623M |
| March 31, 2013 | 6.646M |
| December 31, 2012 | 6.946M |
| September 30, 2012 | 7.063M |
| June 30, 2012 | 6.193M |
| March 31, 2012 | 9.849M |
| December 31, 2011 | 11.02M |
| September 30, 2011 | 12.82M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
6.599M
Minimum
Dec 2019
15.20M
Maximum
Jun 2023
10.88M
Average
9.934M
Median
Dec 2020
Revenue (TTM) Benchmarks
| Eyenovia Inc | -- |
| Palatin Technologies Inc | 7.098M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |